Does Transcatheter Mitral Valve Replacement using the Cardiovalve System provide sustained clinical and echocardiographic success in high-risk MR patients?
Cardiovalve TMVR provides sustained clinical and echocardiographic benefits up to 5 years in high-risk patients with mitral regurgitation.
Cardiovalve TMVR offers a promising long-term option for high-risk MR patients with sustained clinical and echocardiographic success over 5 years.
Benetis et al. (Wed,) studied this question.